•
Dec 31, 2021

Seres Therapeutics Q4 2021 Earnings Report

Total Revenue
$7.22M
Previous year: $17.6M
-58.9%
EPS
-$0.55
Previous year: -$0.19
+189.5%
Gross Profit
-$29.5M
Previous year: -$7.3M
+304.4%
Cash and Equivalents
$180M
Previous year: $116M
+55.1%
Free Cash Flow
-$53.4M
Previous year: -$18.2M
+194.4%
Total Assets
$355M
Previous year: $343M
+3.5%

Seres Therapeutics

Seres Therapeutics